Search Results | Showing 181 - 190 of 240 results for "Pharmaceutical" |
| | | The Australian stock market is expected to open firmer on the back of a positive finish on Wall Street overnight and a surge in metals prices. At 0730 AEST, on the Sydney Futures exchange, the June share price index was up 44 points at 5,761. In equities ... |
| | | | ... cent, to 5,672.6. NEW YORK - US stocks ended little changed on Tuesday as setbacks for two drugs weighed down the pharmaceutical sector, offsetting the relief from a retreat in record high crude oil prices. Trading volume was scant as investors turned ... |
| | | | Inflation has smashed through the 4 per cent barrier to reach 4.2 per cent for the year to March, killing any hopes that interest rates may be about to head south. Highlighting the flashpoint, the ABS has reported that the March quarter rise at 1.3 ... |
| | | | The Australian sharemarket has received mixed leads from overseas. The local market is expected to be buoyed by a strong lead from Wall Street overnight but dragged down by base metal prices which ended lower on the London Metal Exchange on Thursday. ... |
| | | | As competition in Australian banking continues to intensify, ANZ bank is adopting new technologies in India to lead the pack, according to Mike Smith, ANZ's chief executive. Speaking at the Trans-Tasman Business Circle yesterday, Smith said in terms ... |
| | | | ... Nasdaq Composite Index reversed 34.66 points to 2,562.15. LONDON - UK stocks rose 1.4 per cent, led by utilitiy and pharmaceutical stocks. The FTSE 100 added 84.4 to 6,155.3. FRANKFURT - The DAX index rose 43.68 points to 7,562.1. PARIS - The CAC-40 ... |
| | | | ... investment focus will be renewable energy stocks, environmentally focused technology stocks, medical, biotechnology and pharmaceutical companies, education and communications stocks and emerging and esoteric activities such as microfinance and carbon ... |
| | | | ... closed at 5,803.93 points, down 32.26 or 0.55 per cent. TOKYO - Japan's Nikkei average fell 0.3 per cent as Takeda Pharmaceutical dropped after US health authorities recommended it stop some trials of a key drug, while chip-related issues lost ground ... |
| | | | ... as investors shied away from making big bets before Friday's US jobs data. Though caution prevailed, shares of pharmaceutical companies such as Merck & Co and those of utilities rose, countering profit-taking among recently strong oil and technology ... |
| | | | ... and SEQUAL publishes its report on reverse mortgages. Mining and exploration company NiPlats Australia Ltd and pharmaceutical firm Helicon Group Ltd list on the ASX. The Australian share market closed in positive territory on Thursday, underpinned by ... |
|